Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Introduction of a new in vitro approach for prediction of drug-drug interactions based on measurement of intracellular unbound concentrations of time-dependent inhibitors of CYP3A4

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: FILPPULA, Anne (Uppsala, Sweden)
  • Co-author(s): Rezvan Parvizi: Department of Pharmacy, Uppsala University, Uppsala, Sweden
    Anne M Filppula: Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, Uppsala, Sweden
    André Mateus: Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, Uppsala, Sweden
    Pawel Baranczewski: Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, Uppsala, Sweden
    Per Artursson: Department of Pharmacy, Uppsala University, Uppsala, Sweden;Uppsala Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy, Uppsala University, Uppsala, Sweden;SciLifeLab Drug Discovery and Development Platform, ADME of Therapeutics facility, Department of Pharmacy, Uppsala University, Uppsala,
  • Abstract:

    Backgrounds

    Time-dependent inhibition (TDI) of cytochrome P450 (CYP) 3A4 may result in severe and long-lasting clinical drug-drug interactions (DDIs). However, predictions based on in vitro TDI data tend to over-estimate the risk of DDIs, likely due to conservative inhibitor concentration estimates (Vieira et al, 2014).

    Aims

    The aim of this study was

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses